Hallucinations with tolterodine.

作者信息

Williams Scott G, Staudenmeier James

出版信息

Psychiatr Serv. 2004 Nov;55(11):1318-9. doi: 10.1176/appi.ps.55.11.1318-a.

DOI:10.1176/appi.ps.55.11.1318-a

PMID:15534031

Abstract

摘要

相似文献

Hallucinations with tolterodine.

Psychiatr Serv. 2004 Nov;55(11):1318-9. doi: 10.1176/appi.ps.55.11.1318-a.

Tolterodine.

Nurs Times. 2006;102(23):27.

Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.

Am J Manag Care. 2005 Jul;11(4 Suppl):S158-62.

Transient memory impairment and hallucinations associated with tolterodine use.

N Engl J Med. 2003 Dec 4;349(23):2274-5. doi: 10.1056/NEJM200312043492325.

[Overactive bladder. New anticholinergic drug controls urinary urge].

MMW Fortschr Med. 2004 Jul 8;146(27-28):51.

The newer antimuscarinic drugs: bladder control with less dry mouth.

Cleve Clin J Med. 2002 Oct;69(10):761, 765-6, 768-9. doi: 10.3949/ccjm.69.10.761.

[Therapy of mixed urinary incontinence].

Urologe A. 2003 Jun;42(6):812-7. doi: 10.1007/s00120-003-0367-7. Epub 2003 Apr 15.

Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.

Int Urol Nephrol. 2005;37(2):247-52. doi: 10.1007/s11255-004-4703-7.

Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury.

BJU Int. 1999 Dec;84(9):1109. doi: 10.1046/j.1464-410x.1999.00373.x.

Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464-70.

Eur Urol. 2006 Jan;49(1):187-8; author reply 188-90. doi: 10.1016/j.eururo.2005.09.013. Epub 2005 Nov 15.

引用本文的文献

Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.

Drugs Aging. 2015 Jul;32(7):559-67. doi: 10.1007/s40266-015-0281-x.

Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.

Korean J Urol. 2013 Dec;54(12):806-15. doi: 10.4111/kju.2013.54.12.806. Epub 2013 Dec 10.

Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.

Curr Urol Rep. 2011 Oct;12(5):351-7. doi: 10.1007/s11934-011-0198-9.

Vulnerable elderly patients and overactive bladder syndrome.

Drugs Aging. 2010 Sep 1;27(9):697-713. doi: 10.2165/11539020-000000000-00000.

Overactive bladder in the elderly: a guide to pharmacological management.

Drugs Aging. 2005;22(12):1013-28. doi: 10.2165/00002512-200522120-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验